IDEAYA Biosciences, Inc.
IDYA
$33.09
$0.260.79%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 639.39M | 786.89M | 669.74M | 692.51M | 676.32M |
| Total Receivables | 5.97M | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 21.37M | 15.76M | 15.86M | 15.36M | 13.39M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 666.73M | 802.66M | 685.60M | 707.87M | 689.71M |
|
|
|||||
| Total Current Assets | 666.73M | 802.66M | 685.60M | 707.87M | 689.71M |
| Net Property, Plant & Equipment | 31.29M | 31.72M | 32.73M | 33.30M | 27.74M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.02M | 805.00K | 805.00K | 805.00K | 805.00K |
| Total Assets | 1.11B | 1.19B | 1.04B | 1.10B | 1.12B |
|
|
|||||
| Total Accounts Payable | 17.58M | 18.43M | 17.27M | 17.63M | 15.42M |
| Total Accrued Expenses | 40.89M | 45.26M | 37.75M | 32.91M | 30.35M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 339.00K | 328.00K | 318.00K | 308.00K | 298.00K |
| Total Finance Division Other Current Liabilities | -- | 490.00K | -- | -- | -- |
| Total Other Current Liabilities | -- | 490.00K | -- | -- | -- |
| Total Current Liabilities | 58.82M | 64.51M | 55.34M | 50.85M | 46.07M |
|
|
|||||
| Total Current Liabilities | 58.82M | 64.51M | 55.34M | 50.85M | 46.07M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 27.58M | 26.92M | 26.28M | 25.66M | 18.87M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 1.68M | -- | -- | -- |
| Total Liabilities | 86.39M | 93.10M | 81.62M | 76.51M | 64.94M |
|
|
|||||
| Common Stock & APIC | 1.76B | 1.74B | 1.73B | 1.72B | 1.68B |
| Retained Earnings | -736.54M | -653.27M | -772.51M | -695.02M | -622.84M |
| Treasury Stock & Other | 2.27M | 2.05M | 1.52M | 1.59M | 812.00K |
| Total Common Equity | 1.02B | 1.09B | 959.65M | 1.02B | 1.06B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.02B | 1.09B | 959.65M | 1.02B | 1.06B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.02B | 1.09B | 959.65M | 1.02B | 1.06B |
|
|
|||||